These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 6437414)

  • 21. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.
    Becker LC
    J Clin Invest; 1976 Dec; 58(6):1287-96. PubMed ID: 825534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of nitroglycerin-, nitroprusside-, and phentolamine-induced changes in coronary collateral function in dogs.
    Capurro NL; Kent KM; Epstein SE
    J Clin Invest; 1977 Aug; 60(2):295-301. PubMed ID: 406277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of nitroglycerin on coronary circulation of the ischemic region in dogs].
    Chen SL; Zhu MZ; Li LS; Zang YM
    Yao Xue Xue Bao; 1990; 25(10):721-6. PubMed ID: 2129179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nitroglycerin and aortic occlusion on myocardial blood flow.
    Hummel BW; Raess DH; Gewertz BL; Wheeler HT; Fry WJ
    Surgery; 1982 Aug; 92(2):159-66. PubMed ID: 6808681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic study of the hemodynamic effects of sublingual nitroglycerin in unanesthetized dogs.
    Nonaka K; Ueno A
    Arch Int Pharmacodyn Ther; 1991; 312():5-26. PubMed ID: 1772340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic effect of nitroglycerin on coronary hemodynamics in normal subjects.
    Simonetti I; Rossen JD; Winniford MD; Marcus ML
    Z Kardiol; 1989; 78 Suppl 2():52-5; discussion 64-7. PubMed ID: 2511694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acetylcholine on large and small coronary arteries in conscious dogs.
    Cox DA; Hintze TH; Vatner SF
    J Pharmacol Exp Ther; 1983 Jun; 225(3):764-9. PubMed ID: 6864532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute haemodynamic effects of intravenous administration of trapidil in man.
    Di Donato M; Dabizzi RP; Maioli M; Fantini F
    Arzneimittelforschung; 1985; 35(8):1295-8. PubMed ID: 4074447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nitroglycerin on transmural energy metabolism in the underperfused canine heart.
    Higuchi M
    J Pharmacol Exp Ther; 1982 Sep; 222(3):694-8. PubMed ID: 6809931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ITF 296, a new endothelium-independent vasodilator: comparison with nitroglycerin and isosorbide dinitrate.
    Ghaleh B; Dubois-Randé JL; Hittinger L; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S6-12. PubMed ID: 8839220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine.
    Shen YT; Vatner SF
    J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of drugs and sympathetic nerve stimuation on retrograde coronary blood flow in dogs with experimental coronary occlusion.
    Takenaka F; Matuo M; Ishihara T
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):75-85. PubMed ID: 239650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of E4080, a novel bradycardic agent with a coronary vasodilating property, on coronary and systemic hemodynamics in conscious dogs.
    Adachi H
    J Pharmacol Exp Ther; 1994 Jan; 268(1):133-8. PubMed ID: 8301548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological properties of trapidil: comparison with other coronary vasodilators (author's transl)].
    Ohnishi H; Kosuzume H; Yamaguchi K; Sato M; Umehara S; Funato H; Itoh C; Suzuki K; Kitamura Y; Suzuki Y; Itoh R
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):495-503. PubMed ID: 7009345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
    Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of cardiovascular action of trapidil.
    Satoh K; Yamashita S; Endoh M; Taira N
    Arzneimittelforschung; 1980; 30(8):1264-8. PubMed ID: 6254546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ; Hintze TH; Kaley G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.